Identity
HGNC
LOCATION
19q13.32
LOCUSID
ALIAS
ANOVA,NEDASB,NOVA-2,NOVA3
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 4858
MIM: 601991
HGNC: 7887
Ensembl: ENSG00000104967
Variants:
dbSNP: 4858
ClinVar: 4858
TCGA: ENSG00000104967
COSMIC: NOVA2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000104967 | ENST00000263257 | Q9UNW9 |
| ENSG00000104967 | ENST00000596784 | M0R1A0 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35927413 | 2023 | Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function. | 1 |
| 37175811 | 2023 | Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. | 2 |
| 37534933 | 2023 | METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism. | 0 |
| 37864285 | 2023 | Circ_0102231 inactivates the PI3K/AKT signaling pathway by regulating the miR-635/NOVA2 pathway to promote the progression of non-small cell lung cancer. | 1 |
| 37920146 | 2023 | Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR-330-5p. | 4 |
| 35927413 | 2023 | Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function. | 1 |
| 37175811 | 2023 | Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. | 2 |
| 37534933 | 2023 | METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism. | 0 |
| 37864285 | 2023 | Circ_0102231 inactivates the PI3K/AKT signaling pathway by regulating the miR-635/NOVA2 pathway to promote the progression of non-small cell lung cancer. | 1 |
| 37920146 | 2023 | Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR-330-5p. | 4 |
| 34990795 | 2022 | PART1 destabilized by NOVA2 regulates blood-brain barrier permeability in endothelial cells via STAU1-mediated mRNA degradation. | 3 |
| 35239092 | 2022 | Circ_0016760 Serves as a Cancer Promoter in Non-small Cell Lung Cancer Through miR-876-3p/NOVA2 Axis. | 3 |
| 35607920 | 2022 | De novo truncating NOVA2 variants affect alternative splicing and lead to heterogeneous neurodevelopmental phenotypes. | 2 |
| 34990795 | 2022 | PART1 destabilized by NOVA2 regulates blood-brain barrier permeability in endothelial cells via STAU1-mediated mRNA degradation. | 3 |
| 35239092 | 2022 | Circ_0016760 Serves as a Cancer Promoter in Non-small Cell Lung Cancer Through miR-876-3p/NOVA2 Axis. | 3 |
Citation
Dessen P
NOVA2 (NOVA alternative splicing regulator 2)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/41561/nova2
